**
A recent study led by the University of Edinburgh has unveiled alarming delays in the diagnosis of hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS) in the UK, with some patients waiting as long as 21 years for an accurate assessment. This research, involving over 2,000 participants, highlights a critical gap in awareness and understanding among healthcare professionals, which has significant implications for patient care and overall quality of life.
Chronic Pain and Fragmented Healthcare
Individuals suffering from hypermobility-related conditions endure a range of debilitating symptoms, including chronic pain, fatigue, and frequent joint dislocations. The study indicates that many patients experience a fragmented healthcare system, exacerbating their physical and mental health challenges.
Nearly 84% of respondents reported chronic pain, while 74% experienced partially dislocated joints. Additionally, a significant proportion of participants—63%—reported symptoms of depression and 71% experienced anxiety. The pervasive nature of these conditions affects not only physical health but also mental well-being, education, and employment prospects. With 46% of those surveyed unemployed and nearly half receiving disability-related benefits, the socioeconomic impact is stark.
A Prolonged Diagnostic Journey
The research’s findings on diagnostic timelines are particularly concerning. Patients in Wales reported the longest wait for diagnosis, averaging 21.7 years from the onset of symptoms to receiving a definitive diagnosis. Northern Ireland followed closely with an average of 21.1 years, while Scotland and England reported slightly shorter waits of 19.5 and 19 years, respectively. This prolonged journey to diagnosis often forces patients to seek care outside their home regions, with over a third of Welsh and Northern Irish respondents travelling elsewhere in the UK for proper assessment. Notably, 98% of English respondents were able to secure a diagnosis within their home country.
The Call for Systemic Change
Kathryn Berg, the trial and data manager at the University’s Institute of Genetics and Cancer, emphasised the urgent need for comprehensive care pathways that cater to the complex nature of these conditions. Her statements reflect a growing recognition of the necessity for equitable and multidisciplinary approaches in healthcare.
In response to the findings, a spokesperson for the Welsh government acknowledged the challenges faced by patients in their region and indicated ongoing efforts to develop a community health pathway aimed at providing consistent care. Similarly, a UK government spokesperson highlighted the importance of recognising and addressing the needs of individuals with hypermobility disorders, underscoring the detrimental effects of prolonged diagnostic delays on patients and their families.
Enhancing Awareness Among Healthcare Professionals
The lack of awareness among healthcare professionals regarding hypermobility disorders is a critical barrier to timely diagnosis and effective treatment. The Royal College of General Practitioners, in collaboration with EDS Support UK, has created a toolkit for clinicians to enhance their understanding and management of these complex conditions. This initiative aims to improve recognition and ensure that those affected receive the necessary support and care.
Why it Matters
The findings from this study underscore the urgent need for systemic change in how hypermobility disorders are diagnosed and managed within the UK healthcare system. With patients enduring lengthy waits for diagnosis and grappling with a multitude of debilitating symptoms, it is imperative that healthcare professionals are equipped with the knowledge and tools to identify these conditions promptly. The ripple effects of these delays extend beyond individual health, impacting mental well-being, educational achievements, and employment opportunities. Addressing these issues is not merely a matter of improving healthcare; it is a fundamental obligation to enhance the quality of life for those affected by these challenging disorders.
